Grape wine seed extracts slow down the growth rate of Cancer

April 5th, 2012|


Researchers from Colorado Cancer Center have found that grape seed extract can destroy cancer cell which target the head and neck of human body. The study shows that Grape Seed extract lowers the growth rate of certain Cancers by up to 67%.

Lens produces hours of scientific work in seconds

February 24th, 2012|

To meet the growing needs to examine much larger tissue samples, researchers at the University of Strathclyde in Glasgow, Scotland has developed the 70cm mesolens, with its 8cm diameter, the only device in the world which will be able to capture details in organisms which are too big to be examined, in just a second to improve the development of new drugs.

India plans to amend its Drugs and Cosmetics Act

February 6th, 2012|

India’s health ministry is planning to amend 72-year-old Drugs and Cosmetics Act in order to recognize medical devices as a separate category. There are currently only 14 medical devices regulated by the Drug Controller General of India (DCGI). Amending the Drugs and Cosmetics Act would bring all medical devices under regulation in India.

Workshop on Epidemiological methods applied to vaccine preventable diseases

February 6th, 2012|

Date: 21 Feb 2012 – 23 Feb 2012
Place: Florence, Italy
Organized by: ECDC,Istituto Superiore di Sanita’ (ISS)
and Agenzia Sanitaria Locale (ASL)

Epidemiological methods applied to vaccine preventable diseases is a 3 day workshop which will focus on building the capacity to organize, manage, and conduct training on epidemiological methods applied to vaccine-preventable diseases (VPD). The goal is to improve the participants’ skills as trainers.

FDA approves Inlyta to treat advanced Kidney Cancer patients

February 6th, 2012|

Recently U.S. Food and Drug Administration has approved INLYTA(R) axitinib, a kinase inhibitor, for the treatment of patients with advanced renal cell carcinoma (RCC) who have not responded to another drug for this type of cancer.

Determining the Preclinical Toxicokinetic Comparability for a Biosimilar Drug

February 6th, 2012|

Programs for biosimilar drugs usually need at least one preclinical study to support the clinical phase of development. This study must have pharmacokinetic, immunogenicity and toxicological components and provide insight into the similarities and differences (i.e., comparability) between the biosimilar and the innovator drug.

Antares Pharma Licenses A Drug Delivery Technology To Pfizer

January 10th, 2012|

Antares Pharma has recently announced that it has licensed to Pfizer Inc.’s Consumer Healthcare Business Unit one of its drug delivery technologies to develop an undisclosed product on an exclusive basis for North America. The companies did not disclose specifics of the deal.

Research partnership between Humana and Pfizer

January 4th, 2012|

Humana, one of the nation's largest health care companies, and Pfizer, the world's largest biopharmaceutical company, have recently linked together to explore new ideas and ways to improve the quality, outcomes and costs of the health care delivery system for senior citizens and other population.

Anti Measles Vaccination Drive

January 4th, 2012|

Every year large number of children die of measles, keeping this in mind the Centre has launched a massive anti-measles vaccination drive targeting 57 lakh children in the age group of 9 to 10 years. More than 13 crore children are expected to be covered under the Measles Catch-up Campaign, irrespective of their previous measles vaccination status.

Bat Plant can Fight Against Cancer

January 3rd, 2012|

A new study has been found by The University of Texas Health Science Center at San Antonio that Bat plant, or Tacca chantrieri, could be used to fight cancer.

FDA Warns Against Usage of Needle Free Flu Vaccine

January 3rd, 2012|

Recently, US Food and Drug Administration (FDA) has advised health providers not to use needle free injector devices to administer influenza vaccines, because so far no flu vaccines have been approved for administration using such devices, saying they are approved for only the measles, mumps and rubella vaccine.

Size of Indian Pharma Market

January 3rd, 2012|

Structure / Market Size The US Sector $ 12 billion valued pharmaceutical industry in India is expected to grow at an compound annual growth rate (CAGR) of 10-11 per cent. The industry spends around 18 per cent of its revenue on research and development (R&D).

KG5 a wonder drug to kill cancer

December 21st, 2011|

Scientist have again achieved a great success by developing a new drug KG5, which kills off cancer and also could wipe out some of the most deadly forms of the disease. It also acts by cutting off the blood supply to tumours.This drug is expected to hit the market in 5years.

America’s hottest diet craze

December 13th, 2011|

Thousands of Americans claim that African mango works on losing your weight. An exotic skinny fruit, African mango is day by day becoming the hottest diet for Americans. An African Mango Diet has been called a “wonder weight loss drug”, and many have shared testimonials of the weight loss benefits.

Air freshener dangerous to health

December 13th, 2011|

Air fresheners which are used for clean refreshing house or car may smells sweet but very few people understand how bad air fresheners are for their health. Science has confirmed that though air freshener smells sweet but they may cause lung cancer. People with asthma or allergies may want to avoid air fresheners and other chemicals used to spread fragrant scents through their homes, and their doctors should be aware of the hazards.

New Vaccine for Malaria

December 2nd, 2011|

Malaria has been a serious issue since a long period of time and controlling malaria has been a top goal of international public-health authorities. Caused by parasites transmitted by infected mosquitoes, malaria annually sickens more than 200 million people and kills nearly 800,000, mostly children in Africa. Because children are the most vulnerable to the disease, efforts to develop a vaccine have focused on them.

Teva might launch generic Lipitor: Analysts

December 2nd, 2011|

Israel based pharmaceutical company Teva, the world's biggest generic drug maker, will reportedly be able to exclusively distribute its version of the Lipitor cholesterol-lowering medicine due to its collaboration with Indian pharmaceutical company Ranbaxy, which holds a 180-day permit to distribute the generic drug, Calcalist , it is learned.

Light fights against Cancer

December 2nd, 2011|

Researchers in U.S have discovered that light could be a “promising” tool in the fight against cancer, without damaging the surrounding tissues. They described how a drug could be created which sticks to tumors, but is activated only when hit by specific waves of light.

Coffee lowers risk of Skin Cancer

December 2nd, 2011|

According to a research by American Association for Cancer Research, people who drink coffee are at a reduced risk of developing Basal Cell Carcinoma, the most common form of skin cancer. And the more they drink lesser the risk !!

Indian pharmaceutical industry has tremendous potential to grow from the current levels

February 19th, 2010|

A highly organized sector, the Indian pharmaceutical industry is estimated to be worth $4.5 billion, growing at about 8% to 9% every year.